☆ 4.8 Article

Polymeric STING Pro-agonists for Tumor-Specific Sonodynamic Immunotherapy

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

Jing Hu et al.

Summary: Metastasis often occurs when cancer cells that are dormant after primary tumor treatment become active again. The stimulator of interferon genes (STING) pathway has been identified as a suppressor of metastatic outbreak and a potential therapeutic target to prevent disease relapse. By understanding the determinants of immune reactivity during exit from dormancy, researchers have found that STING activity increases in metastatic progenitors that re-enter the cell cycle and can be dampened by methylation or chromatin repression. Activation of STING function in cancer cells derived from spontaneous metastases eliminates dormant metastasis and prevents spontaneous outbreaks.

NATURE (2023)

Add to Collection

Article Chemistry, Multidisciplinary

Smart Nano-PROTACs Reprogram Tumor Microenvironment for Activatable Photo-metabolic Cancer Immunotherapy

Chi Zhang et al.

Summary: This study introduces smart nano-proteolysis targeting chimeras for photo-metabolic cancer immunotherapy, reprogramming the immunosuppressive tumor microenvironment by utilizing phototherapeutic ablation and cancer-specific protein degradation.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Add to Collection

Article Medicine, Research & Experimental

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

Yujeong Moon et al.

Summary: In this study, the researchers propose a new strategy to enhance cancer immunotherapy by using anti-PD-L1 peptide-conjugated prodrug nanoparticles (PD-NPs). The PD-NPs are taken up by cancer cells and release the drug, resulting in the disruption of immune-suppressing pathways and the enhancement of T lymphocyte immune responses. The results show that PD-NPs accumulate in tumor tissues and recruit a large amount of immune cells, leading to effective antitumor effects. This strategy has the potential to overcome the toxicity and low response rate issues in current cancer immunotherapy.

THERANOSTICS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Activatable Cancer Sono-Immunotherapy using Semiconducting Polymer Nanobodies

Ziling Zeng et al.

Summary: This study reports the development of semiconducting polymers as efficient sonosensitizers and the further development of sono-immunotherapeutic nanobodies. The strategy can achieve immunogenic cell death, release of anti-CTLA-4 antibodies, and promote tumor-killing function through sono-irradiation, providing important insights for precise spatiotemporal control over immunotherapy.

ADVANCED MATERIALS (2022)

Add to Collection

Article Chemistry, Physical

STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity

Eric L. Dane et al.

Summary: Lipid nanodiscs functionalized with STING-activating cyclic dinucleotides demonstrate superior tumour penetration and tumour cell uptake, leading to enhanced antitumour T-cell priming and tumour regression.

NATURE MATERIALS (2022)

Add to Collection

Article Multidisciplinary Sciences

Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy

Chi Zhang et al.

Summary: The authors have developed a pH-responsive and sono-irradiation activatable nanosystem for sono-metabolic cancer immunotherapy, functionalized with anti-PD-L1 and adenosine deaminase. This system can efficiently activate immune effector cells and inhibit immune suppressor cells.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles

Jingchao Li et al.

Summary: This study develops a nanomedicine-based cancer sono-immunotherapy that utilizes a semiconducting polymer to generate high levels of 1O2 and conjugates immunomodulators for targeted tumor treatment. The therapy not only reduces tumors and enhances tumor immunogenicity, but also releases immunomodulators specifically at the tumor site. It shows effective antitumor efficacy and reduces immune-related adverse events in animal models.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Oncology

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors

Ming Yi et al.

Summary: The combination therapy of MSA-2 and YM101 enhances antitumor immunity and effectively overcomes immunotherapy resistance in immune-excluded and immune-desert models.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Article Nanoscience & Nanotechnology

Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration

Kaiting Yang et al.

Summary: Researchers have developed a metal-based polymeric nanoparticle that delivers STING agonists to tumors, disrupting endothelial cells in the tumor vasculature and targeting tumor-associated macrophages to elicit an anti-tumor immune response in hard-to-treat cancer models.

NATURE NANOTECHNOLOGY (2022)

Add to Collection

Review Chemistry, Multidisciplinary

Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy

Jingchao Li et al.

Summary: Immunotherapy harnesses the immune system to eliminate malignant cells, but faces challenges such as limited patient response rates and immune-related adverse events. Electromagnetic nanomaterials can induce immunogenic cell death and are used in combination with cancer immunotherapy for reprogramming the tumor microenvironment.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Add to Collection

Article Nanoscience & Nanotechnology

Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy

Xiaoqi Sun et al.

Summary: Metalloimmunotherapy utilizes metal ions to amplify the anti-tumour immune response promoted by STING agonists, forming nanoparticles that effectively deliver STING agonists and achieve remarkable therapeutic efficacy in multiple tumour models. This work highlights the great potential of coordination nanomedicine for metalloimmunotherapy.

NATURE NANOTECHNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer

Yuyan Jiang et al.

Summary: The authors present a strategy for controlled immune regulation in cancer nano-immunotherapy using a photothermally activatable semiconducting polymeric pro-agonist responsive to second near-infrared window light.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Engineering, Biomedical

Prolonged activation of innate immune pathways by a polyvalent STING agonist

Suxin Li et al.

Summary: A novel polyvalent STING agonist extends the activation of innate-immunity pathways through the formation of STING condensates and leads to synergistic therapeutic outcomes in vivo when combined with the STING ligand cGAMP.

NATURE BIOMEDICAL ENGINEERING (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Transformable Nanosensitizer with Tumor Microenvironment-Activated Sonodynamic Process and Calcium Release for Enhanced Cancer Immunotherapy

Xuan Tan et al.

Summary: The study introduces a smart nanosonosensitizer TiO2@CaP which enhances the generation of reactive oxygen species (ROS) under ultrasound activation, inducing mitochondrial dysfunction in the tumor microenvironment and promoting immunogenic cell death, resulting in T-cell infiltration and systemic antitumor immunity. This approach holds promise for developing TME-activatable sonosensitizers with temporospatial control over antitumor responses.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Add to Collection

Article Engineering, Biomedical

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity

Suah Yang et al.

Summary: The construction of cancer-activated DOX prodrug nanoparticles provides a promising approach to enhance anticancer immune responses while minimizing side effects and systemic immunosuppression. These nanoparticles selectively target cancer cells, inducing cytotoxicity and immunogenic cell death, leading to increased response to checkpoint inhibitor immunotherapy.

BIOMATERIALS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy

Jiwoong Choi et al.

Summary: Immune checkpoint blockade is a promising approach for cancer immunotherapy, but many patients do not respond due to the immunosuppressive tumor microenvironment. This study proposes visible-light-triggered prodrug nanoparticles (LT-NPs) to reverse the immunosuppressive tumor microenvironment and enhance checkpoint blockade immunotherapy, showing promising results in tumor models.

ACS NANO (2021)

Add to Collection

Article Multidisciplinary Sciences

A highly potent ruthenium(II)-sonosensitizer and sonocatalyst for in vivo sonotherapy

Chao Liang et al.

Summary: This study demonstrates that [Ru(bpy)(3)](2+) can serve as a highly efficient sonosensitizer and sonocatalyst, producing therapeutic effects in cancer cells in vitro and effectively destroying mouse tumors in vivo. The findings open up possibilities for the use of polypyridinal metal complexes in noninvasive precise sonotherapy for cancer treatment, addressing the current bottleneck of a lack of efficient and safe sonosensitizers in sonodynamic therapy.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Advanced biotechnology-assisted precise sonodynamic therapy

Yi Zhang et al.

Summary: The article discusses the advantages and potential of photodynamic therapy and sonodynamic therapy in the treatment of deep-seated tumors, as well as imaging-guided precise SDT and recent clinical trials. It also summarizes the strategies for designing sonosensitizers based on tumor environment and structure modifications, as well as the approach of SDT combination therapy.

CHEMICAL SOCIETY REVIEWS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Ultrasound-Activated Sensitizers and Applications

Xiahui Lin et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy

Shuang Liang et al.

ADVANCED MATERIALS (2020)

Add to Collection

Article Multidisciplinary Sciences

An orally available non-nucleotide STING agonist with antitumor activity

Bo-Sheng Pan et al.

SCIENCE (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Multifunctional sonosensitizers in sonodynamic cancer therapy

Subin Son et al.

CHEMICAL SOCIETY REVIEWS (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Development of organic semiconducting materials for deep-tissue optical imaging, phototherapy and photoactivation

Jingchao Li et al.

CHEMICAL SOCIETY REVIEWS (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation

Piao Zhu et al.

ACS NANO (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Metal-Organic-Framework-Derived Carbon Nanostructure Augmented Sonodynamic Cancer Therapy

Xueting Pan et al.

ADVANCED MATERIALS (2018)

Add to Collection

Review Chemistry, Multidisciplinary

Multimodal Biophotonics of Semiconducting Polymer Nanoparticles

Yuyan Jiang et al.

ACCOUNTS OF CHEMICAL RESEARCH (2018)

Add to Collection

Review Chemistry, Multidisciplinary

Micro/Nanoparticle-Augmented Sonodynamic Therapy (SDT): Breaking the Depth Shallow of Photoactivation

Xiaoqin Qian et al.

ADVANCED MATERIALS (2016)

Add to Collection

Review Immunology

Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing

Qi Chen et al.

NATURE IMMUNOLOGY (2016)

Add to Collection

Article Immunology

STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors

Seng-Ryong Woo et al.

IMMUNITY (2014)

Add to Collection

Article Multidisciplinary Sciences

Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway

Lijun Sun et al.

SCIENCE (2013)

Add to Collection

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Add to Collection

Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

Add to Collection

Article Multidisciplinary Sciences

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

Hiroki Ishikawa et al.

NATURE (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.